News

Since its mid-2022 launch, the Tesla Model Y has dominated EV sales, driven by affordable prices, easy charging and dynamic ...
That’s because we’re assessing the latest version of the world’s most popular EV, the Tesla Model Y, against one of its most serious competitors, the Kia EV5. Though both are made in China, one’s an ...
Kate Middleton says she’s navigating a “really, really difficult” period of life after skipping royal events amid her cancer recovery.
While the rainbow bouquet of pride may have faded, there are still plenty of events, coming up in both arts and nightlife for you to enjoy. Check out this week's Going Out.
3 Dividend Stocks With High but Shaky Yields That Are Probably Going to Get Cut By Lee Samaha – Jun 12, 2025 at 12:33PM ...
Paramount Global said Tuesday that the entertainment and media company is cutting 3.5% of its workforce, citing challenges in the broader U.S. economy and in the linear television business.
With what Insmed calls an "outstanding" phase 2 win for its treprostinil palmitil inhalation powder (TPIP) in patients with pulmonary arterial hypertension (PAH), the company is racing to phase 3 ...
The 24 million people who get health coverage via the Affordable Care Act are likely to see significant premium increases next year. Here's why.
3. Can Penn State Improve Their Chances With LaSalle Product? Likely one of, if not, Penn State’s highest Offensive Lineman targets, Grayson McKeogh will be at Penn State this weekend.
The aim of this phase 3 study is to confirm the efficacy and safety of relacorilant + nab-paclitaxel in a larger population. Methods: ROSELLA (NCT05257408) is a randomized, controlled, open-label, ...
NAPOLI 3, a phase 3 study of NALIRIFOX in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC): Final overall survival (OS) analysis and characteristics of the long-term survivors.
Intellia reports a grade 4 liver enzyme elevation in a Nex-Z trial patient; no hospitalization is required, and enrollment remains on track across programs.